What is the recommended ketamine bolus dose and infusion protocol for managing status epilepticus?

Ketamine is NOT a standard or guideline-recommended agent for status epilepticus

Ketamine is not mentioned in any major status epilepticus treatment guidelines as a first-, second-, or even third-line agent. The FDA-approved indications for ketamine are limited to anesthesia induction and maintenance—not seizure management 1. While emerging research shows promise for ketamine in refractory and super-refractory status epilepticus (RSE/SRSE), this represents off-label use without guideline support.

What Guidelines Actually Recommend for Status Epilepticus

First-Line Treatment

• Benzodiazepines (lorazepam, diazepam, or midazolam) are universally recommended as initial therapy 2, 3, 2

Second-Line Treatment (After Benzodiazepine Failure)

Guidelines support any of the following 3:

• Fosphenytoin/Phenytoin: 18-20 mg/kg (or PE/kg) IV
• Valproate: 20-30 mg/kg at 40 mg/min
• Levetiracetam: 30-50 mg/kg IV load at 100 mg/min
• Phenobarbital: 10-20 mg/kg

Third-Line Treatment (Refractory Status Epilepticus)

For seizures continuing despite above agents 3:

• Anesthetic doses of midazolam: 0.15-0.20 mg/kg bolus, then 1-5 mg/kg/min infusion 2
• Propofol: 2 mg/kg bolus, then 3-7 mg/kg/hour infusion 3
• Barbiturates (pentobarbital): 13 mg/kg bolus, then 2-3 mg/kg/hour 3

Ketamine's Role: Super-Refractory Status Epilepticus Only

Ketamine should only be considered when standard first-, second-, and third-line therapies have failed—a situation defined as super-refractory status epilepticus (SRSE). This is not guideline-based but rather supported by emerging research evidence.

Ketamine Dosing Protocol (Based on Research Evidence)

When all standard therapies fail, the following ketamine protocol has shown efficacy:

Initial Bolus:

• Adults: 0.5-3 mg/kg IV over 60 seconds (not rapid push) 4, 5
• Pediatrics: 1-3 mg/kg IV bolus 4, 6

Continuous Infusion:

• Adults: Start at 0.2-1 mg/kg/hour, titrate up to 2-3 mg/kg/hour (range reported 0.2-15 mg/kg/hour) 4, 7, 5, 8
• Pediatrics: 0.5-3 mg/kg/hour 4, 6
• Duration: Typically 1-30 days depending on response 4, 5

Target Response:

• Aim for 50% reduction in seizure burden within 24 hours 7, 8
• Complete seizure cessation achieved in 43-81% of cases 4, 7, 8, 9
• Burst suppression pattern on EEG may indicate adequate dosing 6

Critical Caveats About Ketamine Use

Advantages over GABAergic anesthetics:

• Acts on NMDA receptors (different mechanism than benzodiazepines/propofol/barbiturates) 4, 10
• May avoid intubation in some pediatric cases when used early 6
• Associated with hemodynamic stability and decreased vasopressor requirements (85% of patients weaned off pressors) 5, 8
• No increase in intracranial pressure 8

Important Safety Considerations:

• Must be administered by physicians experienced in airway management 1
• Emergency airway equipment must be immediately available 1
• Respiratory depression can occur, especially with concurrent sedatives 1
• The 100 mg/mL concentration must be diluted before IV administration 1
• Administer antisialagogue prior to reduce secretions 1

Concurrent Therapy:

• Ketamine is typically used alongside other agents (most commonly propofol and midazolam) in 40-100% of cases 4
• Interestingly, propofol co-administration was associated with reduced seizure cessation in one study 7
• More antiseizure medications prior to ketamine correlated with better outcomes 7

Practical Algorithm for Ketamine Consideration

1. Has the patient failed benzodiazepines? If no → use benzodiazepines first
2. Has the patient failed at least one second-line agent (fosphenytoin, valproate, levetiracetam, or phenobarbital)? If no → use guideline-recommended second-line agents
3. Has the patient failed anesthetic doses of midazolam, propofol, or barbiturates? If no → use guideline-recommended anesthetic agents
4. Only if yes to all above → Consider ketamine as a last-resort agent for SRSE

Mortality and Outcomes

• All-cause mortality in SRSE treated with ketamine ranges from 0-59.5% 4, 10
• Mortality is related to underlying etiology (infection, anoxia, metabolic causes), not ketamine itself 4
• Earlier ketamine administration correlates with better outcomes 10
• Seizure recurrence reported in some patients after ketamine discontinuation 4

Bottom Line

Do not use ketamine as a first-, second-, or even third-line agent for status epilepticus. Follow established guidelines using benzodiazepines, then fosphenytoin/valproate/levetiracetam/phenobarbital, then anesthetic agents (midazolam/propofol/barbiturates). Only when these fail should ketamine be considered as a salvage therapy for super-refractory status epilepticus, using bolus doses of 0.5-3 mg/kg followed by infusions of 0.2-3 mg/kg/hour, with appropriate airway management capabilities immediately available.